A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04701658 · COMPLETED
Trial details
- NCT number
- NCT04701658
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2021-06-22
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.